Semaglutide In 2027 Medicare Price Negotiations; Most Other Drugs Lose Exclusivity By Then

15 Products Totaled $41bn In Annual Part D Spending

 
• By Mandy Jackson
  
15 drugs that cost Medicare Part D $41bn in one year are slated for negotiated pricing in 2027 (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Drug Pricing

More from Strategy